Showing results (951-960 of 2,563) with videos related to

Sort By:
Pageof 257
Inflammopharmacology|February 24, 2022
Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trialSepideh Barzin Tond, Laurent Balenci, Nasim Khajavirad, et al.
Inflammopharmacology|October 6, 2021
Myeloid-derived suppressor cells (MDSCs) in brain cancer: challenges and therapeutic strategiesMohammad Salemizadeh Parizi, Fatemeh Salemizadeh Parizi, Saeed Abdolhosseini, et al.
Inflammopharmacology|February 15, 2022
Effect of statins on the plasma/serum levels of inflammatory markers in patients with cardiovascular disease; a systematic review and meta-analysis of randomized clinical trialsMitra Abbasifard, Tahmineh Kandelouei, Saeed Aslani, et al.
Inflammopharmacology|May 1, 2019
Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritisPhilipp Guenthoer, Kerstin Fuchs, Gerald Reischl, et al.
Inflammopharmacology|October 18, 2018
The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trialHadi Bazyar, Hassan Gholinezhad, Leila Moradi, et al.
Inflammopharmacology|January 22, 2022
Rutin ameliorates malaria pathogenesis by modulating inflammatory mechanism: an in vitro and in vivo studyDivya Bhatt, Saurabh Kumar, Parmanand Kumar, et al.
Inflammopharmacology|January 30, 2022
RI75, a curcumin analogue, inhibits tumor necrosis factor-α and interleukin-6 production and exhibits antiallodynic and antiedematogenic activities in miceSarah O A M Costa, Ianny B Rodrigues, Alysson V Braga, et al.
Inflammopharmacology|March 23, 2022
Pharmacological evaluation of anti-arthritic potential of terpinen-4-ol using in vitro and in vivo assaysSania Aslam, Waqas Younis, Muhammad Nasir Hayat Malik, et al.
Inflammopharmacology|April 8, 2022
Nangibotide attenuates osteoarthritis by inhibiting osteoblast apoptosis and TGF-β activity in subchondral boneYiming Zhong, Yiming Xu, Song Xue, et al.
Inflammopharmacology|April 26, 2022
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisonsHayder M Al-Kuraishy, Ali I Al-Gareeb, Luay Alkazmi, et al.
Pageof 257